Zevia PBC (ZVIA) Prices 10.7M Share IPO at $14/sh

Zevia PBC (NYSE: ZVIA) today announced the pricing of its initial public offering of 10,700,000 shares of its Class A common stock at a public offering price of $14.00 per share. The shares are expected to begin trading on the New York Stock Exchange on July 22, 2021 under the ticker symbol “ZVIA.”

In addition, Zevia has granted the underwriters a 30-day option to purchase up to an additional 1,605,000 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 26, 2021 subject to satisfaction of customary closing conditions.

Goldman Sachs & Co. LLC, BofA Securities and Morgan Stanley are acting as lead book-running managers for the proposed offering. Stephens Inc., BMO Capital Markets and Wells Fargo Securities are acting as joint book-running managers. Telsey Advisory Group, Loop Capital Markets, Academy Securities, AmeriVet Securities and Ramirez & Co., Inc. are acting as co-managers.

A registration statement relating to the shares being sold was filed with the U.S. Securities and Exchange Commission and became effective on July 21, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor will there be any sale of any of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering may be made only by means of a prospectus. Copies of the final prospectus related to the offering may be obtained, when available, from:

Goldman Sachs & Co. LLC
Prospectus Department
200 West Street
New York, NY 10282
telephone: 1-866-471-2526
facsimile: 212-902-9316
or by emailing [email protected]

BofA Securities
NC1-004-03-43
200 North College Street, 3rd Floor
Charlotte, NC 28255-0001
Attn: Prospectus Department
or via email: [email protected]

Morgan Stanley & Co. LLC
Attn: Prospectus Department
180 Varick Street, 2nd Floor
New York, NY 10014

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Singularity Future Technology closes $5M registered direct offering
• WhiteFiber closes $310M convertible notes offering at 5% due 2032